U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H22O4
Molecular Weight 338.397
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of LICOCHALCONE A

SMILES

COC1=C(\C=C\C(=O)C2=CC=C(O)C=C2)C=C(C(O)=C1)C(C)(C)C=C

InChI

InChIKey=KAZSKMJFUPEHHW-DHZHZOJOSA-N
InChI=1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+

HIDE SMILES / InChI

Molecular Formula C21H22O4
Molecular Weight 338.397
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Licochalcone A (LicA) is a flavonoid isolated from the famous Chinese medicinal herb Glycyrrhiza uralensis Fisch and has a wide spectrum of pharmacological activities such as anti-oxidant, anti-bacterial, anti-viral, and anti-cancer. However, its pharmacological mechanism is not well defined. The anti-Inflammatory effects of LicA on IL-1β-Stimulated human osteoarthritis chondrocytes was reached by activating Nrf2 signaling pathway. LicA showed anti-proliferative and apoptotic effects in breast cancer cells through regulating Sp1 and apoptosis-related proteins in a dose- and a time-dependent manner. In addition, the chemotherapeutic potential of LicA for treatment of human cervical cancer was achieved by inhibition of PI3K/Akt/mTOR signaling.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P08047
Gene ID: 6667.0
Gene Symbol: SP1
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Curative
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Anti-human immunodeficiency virus phenolics from licorice.
1988 Jun
Phenolic constituents of licorice. II. Structures of licopyranocoumarin, licoarylcoumarin and glisoflavone, and inhibitory effects of licorice phenolics on xanthine oxidase.
1989 Nov
Cytotoxic activity of low molecular weight polyphenols against human oral tumor cell lines.
2000 Jul-Aug
Transcriptional suppression of the HIV promoter by natural compounds.
2003 Mar
Natural antimycobacterial metabolites: current status.
2004 Apr
Inhibition by licochalcone A, a novel flavonoid isolated from liquorice root, of IL-1beta-induced PGE2 production in human skin fibroblasts.
2005 Dec
Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
2011 Nov
Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species.
2014 Mar
Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It.
2015 Aug 17
Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) by Glycyrrhiza Species Used for Women's Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A.
2015 Nov 16
Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
2015 Oct
Patents

Sample Use Guides

Nude mice inoculated with Human cervical cancer cell lines (SiHa) were fed with 0, 10, or 20 mg/kg Licochalcone A
Route of Administration: Oral
It was investigated the anti-osteoarthritic effects of licochalcone A (Lico A) in rat chondrocytes. Polymerase chain reaction and Western blotting were performed to evaluate the expression of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-5, ADAMTS-4, collagen II, matrix metalloproteinase (MMP)-13 and MMP-1 at both the gene and protein levels, respectively. In addition, the wnt/β-catenin and nuclear factor kappa B (NF-κB) signaling pathways were also analyzed by Western blotting. Lico A downregulated ADAMTS-5, ADAMTS-4,MMP-13 and MMP-1 expression, and diminished the IL-1β-induced inhibition of collagen II. In addition, the activation of β-catenin and phosphorylation of p65 and IKKα/β were suppressed by Lico A.
Substance Class Chemical
Created
by admin
on Sat Dec 16 04:19:05 GMT 2023
Edited
by admin
on Sat Dec 16 04:19:05 GMT 2023
Record UNII
JTV5467968
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LICOCHALCONE A
MI   WHO-DD  
Common Name English
2-PROPEN-1-ONE, 3-(5-(1,1-DIMETHYL-2-PROPENYL)-4-HYDROXY-2-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-, (E)-
Systematic Name English
LICOCHALCONE A [MI]
Common Name English
(2E)-3-(5-(1,1-DIMETHYL-2-PROPENYL)-4-HYDROXY-2-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-2-PROPEN-1-ONE
Systematic Name English
Licochalcone A [WHO-DD]
Common Name English
2-PROPEN-1-ONE, 3-(5-(1,1-DIMETHYL-2-PROPENYL)-4-HYDROXY-2-METHOXYPHENYL)-1-(4-HYDROXYPHENYL)-, (2E)-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C2189
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C148179
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY
MERCK INDEX
m6802
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY Merck Index
WIKIPEDIA
LICOCHALCONE A
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY
CAS
87080-27-1
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
EVMPD
SUB184387
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY
PUBCHEM
5318998
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY
CAS
58749-22-7
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY
SMS_ID
100000170400
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY
EPA CompTox
DTXSID10904181
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY
FDA UNII
JTV5467968
Created by admin on Sat Dec 16 04:19:05 GMT 2023 , Edited by admin on Sat Dec 16 04:19:05 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT
LICOCHALCONE A exhibited antimicrobial activity (MICs 3.13?12.5 ug/ml) against MSSAs (strains FDA 209P and Smith) and MRSAs(strains K3 and ST 28).
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT
Anti-HCV activity IC50 was found to be be 2.5 ug/mL.
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT
0.64% of dry weight of contents.
Related Record Type Details
ACTIVE MOIETY